Centric Medical Gains FDA 510(k) Clearance of Subtalar Arthroereisis Implant

Centric Medical received FDA 510(k) clearance to market the Subtalar Arthroereisis Implant to treat hyperpronation of the foot and support stabilization of the subtalar joint. Limited release will occur at the end of 2016, with full launch following in 1Q17.

This is the fourth 510(k) clearance in a year for Centric Medical, and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us